Metraipolis › archive › dc_2ca2bccd86d4

Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations — Europe PMC PMID:41020498

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41020498
DOI: 10.1093/nar/gkaf778
License (as archived): solo-consultazione
Archived: 2026-11-10T04:26:43.789Z
SHA-256 of the archived text: 3714476342bbdfd7368fbd1a0d3d1b8c310fdbaecf5c374cd97995d1d89dc658
Stable URL of this page: https://metraipolis.com/documento/dc_2ca2bccd86d4

How to cite

Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations — Europe PMC PMID:41020498 — Europe PMC (en), https://europepmc.org/article/MED/41020498 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ca2bccd86d4 (Metraipolis archive dc_2ca2bccd86d4, sha256 3714476342bbdfd7368fbd1a0d3d1b8c310fdbaecf5c374cd97995d1d89dc658)

BibTeX

@misc{dc2ca2bccd86d4,
  title = {Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations — Europe PMC PMID:41020498},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41020498},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ca2bccd86d4; sha256 3714476342bbdfd7368fbd1a0d3d1b8c310fdbaecf5c374cd97995d1d89dc658},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41020498. Agents can read the archived copy with the MCP tool read_document.